Hengtong Co., Ltd.: Plans to acquire a 40% stake in Aolong Biological for 274 million yuan

2026-03-13 10:10:19

People’s Financial News, March 13 — Hengtong Co., Ltd. (600226) announced on March 13 that the company plans to acquire a 40% stake in Aolong Biological, held by Huapai Biological, using its own funds or self-raised funds. After negotiations between both parties, the transfer price for the 40% stake in Aolong Biological is 274 million yuan. This transaction will enhance the company’s product layout in the biotech field, providing customers with a comprehensive product matrix that includes veterinary vaccines, veterinary drugs, feed additives, and more. Additionally, the company can achieve channel sharing and R&D collaboration with the target company, build core technological barriers, and further increase its market share.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes